Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the mfn-opts domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6121
Evidence Puts America’s Mail-Order Abortion Policy on Trial, by Jacqueline O’Hara – Brown Pelican Society of Lousiana

Evidence Puts America’s Mail-Order Abortion Policy on Trial, by Jacqueline O’Hara

The Disturbing Doctor Touring the Country to Promote Her Career of Third-Trimester Abortions, by Ellie Gardey Holmes
February 26, 2026
Lent: February 26th Including Today’s Saint: St. Porphyrius, Bishop (RM) (February 26th)
February 26, 2026

Gavel image: Wesley Tingey/Unsplash.com; Mifepristone pills: Yuchacz/Wikipedia

By Jacqueline O’Hara, Catholic Herald, February 25, 2026

In recent years, the language of ‘medical consensus’ has been invoked to shut down debate over some of the most divisive ethical questions in America. Mounting legal challenges suggest that what is often described by partisans on one side of the debate as ‘settled science’ may, in fact, be shaped as much by politics as it is by evidence. Nowhere is this tension clearer than in the fight over mifepristone.

Pro-abortion activists have spent years downplaying the serious and potentially life-threatening harms associated with mifepristone on the grounds that the medical community says the science of the abortion drug is ‘settled’.  Research data is now beginning to suggest otherwise, evidence to which we can add the lived experiences of countless women. A recent report found that the rate of serious adverse events (SAEs) associated with mifepristone is over 20 times higher than what the FDA currently reports and that an estimated 70,000 women likely experienced a mifepristone-related SAE in 2023 alone. …

Continue reading >>>>>>>>>>>